Previous studies had revealed that CDCA2 might be an oncogene in some cancers, such as luminal breast cancer 17, lung adenocarcinoma 18 and pancreatic ductal adenocarcinoma. This evidence concerns the gene CDCA2 and lung adenocarcinoma.